Applied DNA Sciences, Inc. (NASDAQ:APDN) Short Interest Update

Applied DNA Sciences, Inc. (NASDAQ:APDN) was the target of a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 611,100 shares, a drop of 28.4% from the October 15th total of 853,200 shares. Based on an average daily volume of 11,550,000 shares, the days-to-cover ratio is currently 0.1 days.

Institutional Trading of Applied DNA Sciences

A hedge fund recently bought a new stake in Applied DNA Sciences stock. Jane Street Group LLC purchased a new stake in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 73,396 shares of the technology company’s stock, valued at approximately $48,000. Jane Street Group LLC owned 0.24% of Applied DNA Sciences at the end of the most recent quarter. Institutional investors own 22.22% of the company’s stock.

Applied DNA Sciences Stock Performance

Shares of NASDAQ:APDN opened at $0.16 on Friday. The firm has a 50 day simple moving average of $0.60 and a 200 day simple moving average of $1.03. Applied DNA Sciences has a 52 week low of $0.15 and a 52 week high of $22.80. The company has a market cap of $5.06 million, a PE ratio of -0.01 and a beta of 0.46.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded Applied DNA Sciences to a “sell” rating in a report on Tuesday, September 17th.

About Applied DNA Sciences

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.